Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (321-330 of 551) with videos related to

Pageof 56
Sort By:
Plos One|August 4, 2023
Increased frequency and quantity of mucosal and plasma cytomegalovirus replication among Ugandan Adults Living with HIVElisabeth McClymont, Jeffrey Bone, Jackson Orem, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2013
HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infectionTomer Hertz, Christine M Oshansky, Philippa L Roddam, et al.
Infectious Diseases and Therapy|January 11, 2023
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USAMindy M Cheng, Carolina Reyes, Sacha Satram, et al.
Frontiers in Immunology|April 18, 2022
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV AntigensDavid M Koelle, Lichun Dong, Lichen Jing, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
Plos One|June 7, 2013
Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapyTong Wang, Younong Xu, Haiying Zhu, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsSteven A Pergam, Hu Xie, Ravinder Sandhu, et al.
Sexually Transmitted Diseases|September 16, 2003
Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virusNancy F Crum, Mark R Wallace, Kevin Stephan, et al.
Plos One|April 13, 2012
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccinationCheng Cheng, Lingshu Wang, LingShu Wang, et al.
Pageof 56

Showing results (321-330 of 551) with videos related to

Sort By:
Pageof 56
Plos One|August 4, 2023
Increased frequency and quantity of mucosal and plasma cytomegalovirus replication among Ugandan Adults Living with HIVElisabeth McClymont, Jeffrey Bone, Jackson Orem, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2013
HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infectionTomer Hertz, Christine M Oshansky, Philippa L Roddam, et al.
Infectious Diseases and Therapy|January 11, 2023
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USAMindy M Cheng, Carolina Reyes, Sacha Satram, et al.
Frontiers in Immunology|April 18, 2022
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV AntigensDavid M Koelle, Lichun Dong, Lichen Jing, et al.
AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.
Plos One|June 7, 2013
Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapyTong Wang, Younong Xu, Haiying Zhu, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsSteven A Pergam, Hu Xie, Ravinder Sandhu, et al.
Sexually Transmitted Diseases|September 16, 2003
Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virusNancy F Crum, Mark R Wallace, Kevin Stephan, et al.
Plos One|April 13, 2012
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccinationCheng Cheng, Lingshu Wang, LingShu Wang, et al.
Pageof 56